83 results
8-K
EX-99.2
NVTAQ
Invitae Corp
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
TESTING NEONATAL TESTING PEDIATRIC TESTING CARRIER SCREENING ADULT DIAGNOSTIC THERAPY GUIDANCE PHARMACOGENOMICS RISK ASSESSMENT MRD/RECURRENCE MONITORING
8-K
EX-99.1
NVTAQ
Invitae Corp
13 Nov 19
Invitae to Acquire Clear Genetics
4:09pm
can guide patients regarding consent, personalized risk assessment, insurance benefits, pre/post-test education and understanding their test results
8-K
EX-99.2
NVTAQ
Invitae Corp
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
. Build the platform to enable the shift Develop tests that deliver information to support medicine as it was
A menu that delivers RISK ASSESSMENT
8-K
EX-99.1
zoxml1pn1mw
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
8-K/A
EX-99.2
igc1r
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
9o4u g8clala
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
8-K
EX-99.1
prhsmj 5e9e85
8 Nov 23
Invitae Reports Third Quarter 2023 Financial Results
4:05pm
8-K/A
EX-99.1
dt7ff3n39v5s0xz4v
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.3
e3gwpvy
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
8-K
EX-99.1
n7lblp6mk7qw3oocb5wo
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
8-K
EX-99.1
q9akaiu7yy7d7ofisq
3 Aug 21
Invitae Reports $116.3 Million in Revenue Driven by 287,000 in Billable Volume in Second Quarter of 2021
4:08pm